Prosecution Insights
Last updated: April 19, 2026

Leydig Voit & Mayer, Ltd. (Nih)

24 pending office actions • 5 clients

Portfolio Summary

24
Total Pending OAs
4
Final Rejections
20
Non-Final OAs

Client Portfolio (5 clients)

Client (Assignee)Pending OAs
The United States Department of Health and Human Services 20
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. 1
The United States Department of Health and Human Services 1
The University of Queensland 1
The United States Department of Health and Human Services 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19220496 MULTIDIMENSIONAL MRI SIGNATURE FOR SPECIFIC DETECTION OF TRAUMATIC BRAIN INJURY IN VIVO The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. PEHLKE, CAROLYN A 3799 Non-Final OA May 28, 2025
18722188 METHODS AND SYSTEMS FOR ANALYZING TARGET ENGAGEMENT DATA FROM BIOLOGICAL ASSAYS The United States Department of Health and Human Services MONTGOMERY, ANN Y 1678 Non-Final OA Jun 20, 2024
18662788 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES (2-D CELLS AND 3-D TISSUES) FOR USE IN CELL THERAPY AND TISSUE ENGINEERED PRODUCTS The United States Department of Health and Human Services PARK, SOO JIN 2675 Non-Final OA May 13, 2024
18286911 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION The United States Department of Health and Human Services PAGONAKIS, ANNA 6221 Non-Final OA Oct 13, 2023
18282919 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF The United States Department of Health and Human Services LANDSMAN, ROBERT S 1647 Non-Final OA Sep 19, 2023
18277521 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 The United States Department of Health and Human Services HADDAD, MAHER M 1641 Non-Final OA Aug 16, 2023
18233654 SURGICAL TOOL AND METHOD FOR SOFT OCULAR TISSUE TRANSPLANTATION The United States Department of Health and Human Services YABUT, DIANE D 3771 Final Rejection Aug 14, 2023
18272435 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS The United States Department of Health and Human Services SHTERENGARTS, SAMANTHA L 1623 Non-Final OA Jul 14, 2023
18271583 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF The United States Department of Health and Human Services WEBB, WALTER E 1612 Non-Final OA Jul 10, 2023
18037379 TYROSYL-LOCK PEPTIDES The University of Queensland BRADLEY, CHRISTINA 1654 Non-Final OA May 17, 2023
18028463 PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER The United States Department of Health and Human Services HERNANDEZ, JACKSON J 1627 Final Rejection Mar 24, 2023
17910911 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES The United States Department of Health and Human Services HOBBS, MICHAEL L 1799 Non-Final OA Feb 15, 2023
18020843 REAL-TIME CELLULAR THERMAL SHIFT ASSAY (RT-CETSA) FOR RESEARCH AND DRUG DISCOVERY The United States Department of Health and Human Services TSAY, MARSHA M 1656 Non-Final OA Feb 10, 2023
18076071 PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION The United States Department of Health and Human Services TRAN, LARA LINH 3791 Non-Final OA Dec 06, 2022
18056356 GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC The United States Department of Health and Human Services SHIN, DANA H 1635 Non-Final OA Nov 17, 2022
17918725 THYCLOTIDES The United States Department of Health and Human Services GALSTER, SAMUEL LEONARD 1693 Final Rejection Oct 13, 2022
17912315 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY The United States Department of Health and Human Services BUNKER, AMY M 1684 Non-Final OA Sep 16, 2022
17799193 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION The United States Department of Health and Human Services CANELLA, KAREN A 1643 Non-Final OA Aug 11, 2022
17793753 HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) The United States Department of Health and Human Services HOLLAND, PAUL J 1656 Non-Final OA Jul 19, 2022
17602204 HYBRID NUCLEIC ACID SWITCHES The United States Department of Health and Human Services LIPPOLIS, ALEXANDRA ROSE 1637 Non-Final OA Oct 07, 2021
17429391 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES The United States Department of Health and Human Services ROGERS, ERIC JASON 1638 Non-Final OA Aug 09, 2021
17276959 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD20 AND THEIR USES The United States Department of Health and Human Services JUEDES, AMY E 1644 Non-Final OA Mar 17, 2021
16980205 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES The United States Department of Health and Human Services EDGINGTONGIORDANO, FRANCESCA 1643 Final Rejection Sep 11, 2020
16650696 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION The United States Department of Health and Human Services SABILA, MERCY HELLEN 1654 Non-Final OA Mar 25, 2020

Managing Leydig Voit & Mayer, Ltd. (Nih)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month